Asia
Prescient Therapeutics Launches Share Purchase Plan to Raise Up to AU$7 Million, Shares Fall 7%
Prescient Therapeutics (ASX:PTX) launched a share purchase plan (SPP) to raise up to AU$7 million, with new fully paid ordinary shares to be issued at AU$0.065 per share, according to a Tuesday Australian bourse filing.The company said the issue price represents an 18.8% discount to the volume-weighted average price over the 10 trading days before the SPP was disclosed and a 9.7% discount to the last price.The company's shares fell 7% in recent Tuesday trade.
ASX:PTX
